BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34085510)

  • 1. Safety and efficacy of a strategy of vitamin K antagonist reversal with prothrombin complex concentrates compared to vitamin K in patients with hip fracture.
    Jay-Caillierez L; Friggeri A; Viste A; Lefevre M; Decullier E; Bernard L; Piriou V; David JS
    Can J Surg; 2021 Jun; 64(3):E330-E338. PubMed ID: 34085510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of vitamin K in anticoagulation reversal for hip fracture surgery--a prospective observational study.
    Buecking B; Eschbach D; Bliemel C; Oberkircher L; Struewer J; Ruchholtz S; Sachs UJ
    Thromb Res; 2014 Jan; 133(1):42-7. PubMed ID: 24196230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of prothrombin complex concentrate for reversal of direct oral anticoagulants in clinical practice: indications, patient characteristics and clinical outcomes compared to reversal of vitamin K antagonists.
    Müller M; Eastline J; Nagler M; Exadaktylos AK; Sauter TC
    Scand J Trauma Resusc Emerg Med; 2019 Apr; 27(1):48. PubMed ID: 31014373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrate.
    Majeed A; Meijer K; Larrazabal R; Arnberg F; Luijckx GJ; Roberts RS; Schulman S
    Thromb Haemost; 2014 Feb; 111(2):233-9. PubMed ID: 24154891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of Octaplex for reversal of warfarin anticoagulation in patients with hip fracture.
    Ng R; Shabani-Rad MT
    Can J Surg; 2019 Feb; 62(1):14-19. PubMed ID: 30265643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and effectiveness of a prothrombin complex concentrate in approved and off-label indications.
    Marcos-Jubilar M; García Erce JA; Martínez-Calle N; Páramo JA; Martínez Virto A; Quintana-Díaz M
    Transfus Med; 2019 Aug; 29(4):268-274. PubMed ID: 31347218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight-Based Dosing Versus a Fixed-Dose Regimen of 4-Factor Prothrombin Complex Concentrate in Obese Patients Requiring Vitamin K Antagonist Reversal.
    Elsamadisi P; Cepeda MAG; Yankama T; Wong A; Tran Q; Eche IM
    Am J Cardiovasc Drugs; 2021 May; 21(3):355-361. PubMed ID: 33150496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can oral vitamin K before elective surgery substitute for preoperative heparin bridging in patients on vitamin K antagonists?
    Steib A; Barre J; Mertes M; Morel MH; Nathan N; Ozier Y; Treger M; Samama CM
    J Thromb Haemost; 2010 Mar; 8(3):499-503. PubMed ID: 19912513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergency reversal of anticoagulation with vitamin K antagonists with 3-factor prothrombin complex concentrates in patients with major bleeding.
    Imberti D; Magnacavallo A; Dentali F; Condoleo E; Gallerani M; Benedetti R; Ageno W
    J Thromb Thrombolysis; 2013 Jul; 36(1):102-8. PubMed ID: 23054464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of older hip fracture patients on anticoagulation: a comparison of vitamin K-antagonists and Factor Xa inhibitors.
    Gosch M; Jacobs M; Bail H; Grueninger S; Wicklein S
    Arch Orthop Trauma Surg; 2021 Apr; 141(4):637-643. PubMed ID: 32710342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Events Following International Normalized Ratio Reversal in Intracerebral Hemorrhage.
    Laible M; Jenetzky E; Beynon C; Müller OJ; Sander P; Schüler S; Purrucker J; Möhlenbruch M; Steiner T; Veltkamp R; Ringleb PA; Rizos T
    Cerebrovasc Dis; 2016; 42(5-6):446-454. PubMed ID: 27536779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guideline-concordant administration of prothrombin complex concentrate and vitamin K is associated with decreased mortality in patients with severe bleeding under vitamin K antagonist treatment (EPAHK study).
    Tazarourte K; Riou B; Tremey B; Samama CM; Vicaut E; Vigué B;
    Crit Care; 2014 Apr; 18(2):R81. PubMed ID: 24762166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bridging anticoagulation in patients treated with vitamin K antagonists prior to trochanteric and hip fracture surgeries: The current practice.
    Szklanny K; Jakubek M; Zbierska-Rubinkiewicz K; Undas A
    Adv Clin Exp Med; 2019 Apr; 28(4):469-477. PubMed ID: 30088350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study.
    Sarode R; Milling TJ; Refaai MA; Mangione A; Schneider A; Durn BL; Goldstein JN
    Circulation; 2013 Sep; 128(11):1234-43. PubMed ID: 23935011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is fast reversal and early surgery (within 24 h) in patients on warfarin medication with trochanteric hip fractures safe? A case-control study.
    Mattisson L; Lapidus LJ; Enocson A
    BMC Musculoskelet Disord; 2018 Jun; 19(1):203. PubMed ID: 29945596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling of vitamin K half-life in patients treated with vitamin K antagonists before hip fracture surgery.
    Combettes E; Mazoit JX; Benhamou D; Beloeil H
    Anaesth Crit Care Pain Med; 2015 Oct; 34(5):295-9. PubMed ID: 26638965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial.
    Steiner T; Poli S; Griebe M; Hüsing J; Hajda J; Freiberger A; Bendszus M; Bösel J; Christensen H; Dohmen C; Hennerici M; Kollmer J; Stetefeld H; Wartenberg KE; Weimar C; Hacke W; Veltkamp R
    Lancet Neurol; 2016 May; 15(6):566-73. PubMed ID: 27302126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of prothrombin complex concentrate dosing strategies to reverse vitamin K antagonist therapy.
    Khorsand N; Kooistra HA; van Hest RM; Veeger NJ; Meijer K
    Thromb Res; 2015 Jan; 135(1):9-19. PubMed ID: 25480313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial.
    Goldstein JN; Refaai MA; Milling TJ; Lewis B; Goldberg-Alberts R; Hug BA; Sarode R
    Lancet; 2015 May; 385(9982):2077-87. PubMed ID: 25728933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding.
    Schick KS; Fertmann JM; Jauch KW; Hoffmann JN
    Crit Care; 2009; 13(6):R191. PubMed ID: 19948037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.